Clinical Trial Success Assurance
De-risking clinical trials with data, AI, and deep operational insight, saving costs and bringing innovative medicines to patients faster
Unmanaged risks can derail clinical trial timelines, leading to lost revenues and delaying patients’ access to innovative medicines. With data from over one million clinical trials, advanced analytics and AI, our Trial Success Assurance empowers you to address these clinical trials risks, from early planning through to execution.
A novel approach to clinical trial optimization grounded in big data and AI
The amount of data collected in clinical trials and the requirements imposed by regulators are ever increasing, giving rise to an unprecedented operational complexity. To serve the healthcare industry’s need for effective clinical trial design, Rewire entered a partnership with GoTrial, a platform that collects, harmonizes and curates clinical trial data from worldwide registries, building up a knowledge base of over 1 million clinical trials. Our Trial Success Assurance (TSA) presents a novel lever to optimize study design and execution with an objective assessment grounded in big data.
Modular approach tailored to your needs
We designed TSA as a modular offering to provide fast access to initial diagnostics, and to deep-dive into site selection, protocol optimization or operational oversight as and when needed. The study health check provides a risk assessment of the study setup: within 6 weeks following receipt of the study protocol and the planned sites, our expert team provides actionable insights into study design, protocol, inclusion/exclusion criteria, site selection and operational feasibility based on historic clinical study and site data.
Risk-sharing options with Munich Re
A growing number of clinical trial sponsors seek not only to reduce risk but also to transfer residual risk. In partnership with Munich Re, a global reinsurance and specialty insurance group, TSA provides options to insure against the risks of enrolment shortfalls. This elevates TSA from a planning tool to a strategic enabler of new business models in clinical development.
Implementing AI in clinical trials
Study health check
Deliver objective risk intelligence at the protocol and site level - empowering smarter and faster clinical trial setup, execution and adjustments of ongoing studies
Site optimization
Maximize enrolment success by identifying, prioritizing, and phasing clinical trial sites based on predicted performance, patient access, and competition risk
Protocol optimization
Optimize protocol feasibility and patient accessibility by simulating real-world impact of eligibility criteria, protocol burden, and recruitment complexity
Strategic monitoring
Enable real-time operational oversight and proactive risk management across enrolment, site performance, and competitive dynamics, ensuring trials stay on track throughout execution
Rewire your clinical trials with AI
TSA complements best practices with objective perspectives grounded in big data & advanced analytics
Our track record speaks volumes
40%
Increased patient pool
We identified overly complex and restrictive eligibility criteria that excluded patients who were likely to benefit from treatment in a study that struggled to find eligible patients.
25%
Enrolment target added
We suggested an optimized set of high-potential sites predicted to enrol a significant part of a study's target patients.
Unlock the power of data & AI for your clinical studies today.
Get in touch.
Looking for an objective assessment of your clinical trial, powered by big data & AI?
